Sort
40,608 grants matching “prostate cancer”
CHAPERONE FUNCTION IN ANDROGEN-INDEPENDENT PROSTATE CANCER
$568,125Rector & Visitors Of The University Of Virginia · · FY2009 · Department of the Army
PROSTATE CANCER METASTASIS, CELL-BONE MARROW ADHESION MEDIATORS
$568,100Rector & Visitors Of The University Of Virginia · · FY2008 · Department of Defense
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population
$567,769Marvin Epolian Langston · Stanford University · R01 · FY2025 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$567,760Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
$567,651Kyung Hyun Sung · University Of California Los Angeles · R01 · FY2020 · CA
Ultra-Low Count Quantitative SPECT for Alpha-Particle Therapies
$567,617Abhinav K Jha · Washington University · R01 · FY2025 · EB
Ultra-Low Count Quantitative SPECT for Alpha-Particle Therapies
$567,617Abhinav K Jha · Washington University · R01 · FY2024 · EB
Genetics of Prostate Cancer Susceptibility
$567,521Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA
Develop CEES-induced skin toxicity models and evaluate silibinin efficacy
$567,491Rajesh Agarwal · National Jewish Health · U54 · FY2009 · ES
Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
$567,468Amy Y Zhang · Case Western Reserve University · R01 · FY2012 · CA
Small molecule probes of MYC stability and function intumorigenesis
$567,361Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2021 · CA
Career Development in Pediatric and Medical Oncology
$567,345Soheil Meshinchi · Fred Hutchinson Cancer Center · K12 · FY2023 · CA
RISK FACTORS FOR ADVANCED PROSTATE CANCER
$567,261University Of Southern California · R01 · FY2002 · CA
A Personalized Digital Outreach Intervention for Lung Cancer Screening
$567,242David P Miller · Wake Forest University Health Sciences · R01 · FY2021 · CA
A novel role for EZH2 in PARP regulation and PARPi-resistance in prostate cancer
$567,198Qi Cao · Northwestern University At Chicago · R01 · FY2025 · CA
Enhancing Colorectal CA Screening through Learning Teams
$567,137Benjamin F Crabtree · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2007 · CA
Mammalian Target of Rapamycin in Prostate Carcinogenesis
$567,105Washington University · R01 · FY2005 · CA
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC
$567,087Johannes Czernin · University Of California Los Angeles · R01 · FY2024 · CA
Genetic determinants of gene expression phenotypes in aggressive prostate cancer
$567,060Liang Wang · Medical College Of Wisconsin · R01 · FY2013 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies
$567,040Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
$567,008Michael A Diefenbach · Feinstein Institute For Medical Research · R01 · FY2022 · CA
Revisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism
$566,917Daniel Edward Frigo · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
$566,874Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2012 · CA
Identification of DNA methylation markers for risk of metastasis in localized pro
$566,816Chun R. Chao · Kaiser Foundation Research Institute · R01 · FY2017 · CA
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
$566,741Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA